Mailed smoking cessation support for Aboriginal and Torres Strait Islander people who smoke: protocol for a hybrid type 1 effectiveness – implementation trial
Introduction Smoking is the leading preventable cause of death and the single most significant risk behaviour contributing to adverse health conditions among Aboriginal and Torres Strait Islander people. There is an urgent need for innovative approaches to support reductions in smoking prevalence. T...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-12-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/14/12/e088501.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841537086781390848 |
|---|---|
| author | Raglan Maddox Catherine Chamberlain Billie Bonevski Amanual Getnet Mersha Jamie Bryant Michelle Kennedy Nathan Taylor Cathy Segan Kayden Roberts-Barker Zabowie Mills Kade Booth Joley Foster |
| author_facet | Raglan Maddox Catherine Chamberlain Billie Bonevski Amanual Getnet Mersha Jamie Bryant Michelle Kennedy Nathan Taylor Cathy Segan Kayden Roberts-Barker Zabowie Mills Kade Booth Joley Foster |
| author_sort | Raglan Maddox |
| collection | DOAJ |
| description | Introduction Smoking is the leading preventable cause of death and the single most significant risk behaviour contributing to adverse health conditions among Aboriginal and Torres Strait Islander people. There is an urgent need for innovative approaches to support reductions in smoking prevalence. This study will assess the implementation and effectiveness of a mailed smoking cessation support programme that includes nicotine replacement therapy (NRT) (Which Way Quit Pack) for Aboriginal and Torres Strait Islander people.Methods and analysis A hybrid type 1 effectiveness—implementation trial will be conducted in Australia from 2023 to 2025. A sample of 500 Aboriginal and Torres Strait Islander people aged over 16 who smoke will be recruited using social media. All participants will: (a) receive a mailed Which Way Quit Pack that includes pamphlets and resources on quitting, information about quit smoking support options (MyQuitBuddy App) and a selection of merchandise; (b) be offered a referral to Aboriginal Quitline; and (c) be offered a free 12-week mail out course of combination NRT. Outcome data will be obtained using quantitative surveys and qualitative Yarning. Effectiveness outcomes will include assessment of 7-day point prevalence, continuous abstinence and quit attempts at 3- and 6-month follow-up. Implementation outcomes will include assessment of recruitment and retention rates, intervention uptake and adherence, and intervention acceptability.Cessation data will be analysed using an intention-to-treat principle with all individuals lost to follow-up considered as smoking. Yarns will be analysed by Aboriginal and Torres Strait Islander members of the research team privileging Collaborative Yarning, with the support of a reflexive thematic analysis approach that will identify themes while also reflecting potential biases and perspectives of the researcher throughout the analysis process.Ethics and dissemination Ethics approvals were obtained from Aboriginal Health and Medical Research Council Ethics Committee of NSW (1894/21) and the University of Newcastle (H-2022-0174). Findings will be disseminated through publications, conference presentations and sharing with relevant government bodies.Trial registration number Australian New Zealand Clinical Trials Registry (ACTRN12623001021662). |
| format | Article |
| id | doaj-art-d0f0bb23d7d74f479ff3ea9ca76b2e1e |
| institution | Kabale University |
| issn | 2044-6055 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open |
| spelling | doaj-art-d0f0bb23d7d74f479ff3ea9ca76b2e1e2025-01-14T09:15:11ZengBMJ Publishing GroupBMJ Open2044-60552024-12-01141210.1136/bmjopen-2024-088501Mailed smoking cessation support for Aboriginal and Torres Strait Islander people who smoke: protocol for a hybrid type 1 effectiveness – implementation trialRaglan Maddox0Catherine Chamberlain1Billie Bonevski2Amanual Getnet Mersha3Jamie Bryant4Michelle Kennedy5Nathan Taylor6Cathy Segan7Kayden Roberts-Barker8Zabowie Mills9Kade Booth10Joley Foster11National Centre for Aboriginal and Torres Strait Islander Wellbeing Research, National Centre for Epidemiology and Population Health, Australian National University, Canberra, Australian Capital Territory, Australia4 The University of Melbourne School of Population and Global Health, Melbourne, Victoria, Australia6 Flinders University College of Medicine and Public Health, Bedford Park, South Australia, Australia1 School of Medicine and Public Health, The University of Newcastle, Newcastle, New South Wales, Australia2 Equity in Health and Wellbeing Research Program, The University of Newcastle Hunter Medical Research Institute, New Lambton, New South Wales, Australia1 The University of Newcastle College of Health Medicine and Wellbeing, Callaghan, New South Wales, Australia8 Aboriginal Health & Medical Research Council, Sydney, New South Wales, Australia4 The University of Melbourne School of Population and Global Health, Melbourne, Victoria, Australia1 The University of Newcastle College of Health Medicine and Wellbeing, Callaghan, New South Wales, Australia1 The University of Newcastle College of Health Medicine and Wellbeing, Callaghan, New South Wales, Australia1 The University of Newcastle College of Health Medicine and Wellbeing, Callaghan, New South Wales, Australia1 The University of Newcastle College of Health Medicine and Wellbeing, Callaghan, New South Wales, AustraliaIntroduction Smoking is the leading preventable cause of death and the single most significant risk behaviour contributing to adverse health conditions among Aboriginal and Torres Strait Islander people. There is an urgent need for innovative approaches to support reductions in smoking prevalence. This study will assess the implementation and effectiveness of a mailed smoking cessation support programme that includes nicotine replacement therapy (NRT) (Which Way Quit Pack) for Aboriginal and Torres Strait Islander people.Methods and analysis A hybrid type 1 effectiveness—implementation trial will be conducted in Australia from 2023 to 2025. A sample of 500 Aboriginal and Torres Strait Islander people aged over 16 who smoke will be recruited using social media. All participants will: (a) receive a mailed Which Way Quit Pack that includes pamphlets and resources on quitting, information about quit smoking support options (MyQuitBuddy App) and a selection of merchandise; (b) be offered a referral to Aboriginal Quitline; and (c) be offered a free 12-week mail out course of combination NRT. Outcome data will be obtained using quantitative surveys and qualitative Yarning. Effectiveness outcomes will include assessment of 7-day point prevalence, continuous abstinence and quit attempts at 3- and 6-month follow-up. Implementation outcomes will include assessment of recruitment and retention rates, intervention uptake and adherence, and intervention acceptability.Cessation data will be analysed using an intention-to-treat principle with all individuals lost to follow-up considered as smoking. Yarns will be analysed by Aboriginal and Torres Strait Islander members of the research team privileging Collaborative Yarning, with the support of a reflexive thematic analysis approach that will identify themes while also reflecting potential biases and perspectives of the researcher throughout the analysis process.Ethics and dissemination Ethics approvals were obtained from Aboriginal Health and Medical Research Council Ethics Committee of NSW (1894/21) and the University of Newcastle (H-2022-0174). Findings will be disseminated through publications, conference presentations and sharing with relevant government bodies.Trial registration number Australian New Zealand Clinical Trials Registry (ACTRN12623001021662).https://bmjopen.bmj.com/content/14/12/e088501.full |
| spellingShingle | Raglan Maddox Catherine Chamberlain Billie Bonevski Amanual Getnet Mersha Jamie Bryant Michelle Kennedy Nathan Taylor Cathy Segan Kayden Roberts-Barker Zabowie Mills Kade Booth Joley Foster Mailed smoking cessation support for Aboriginal and Torres Strait Islander people who smoke: protocol for a hybrid type 1 effectiveness – implementation trial BMJ Open |
| title | Mailed smoking cessation support for Aboriginal and Torres Strait Islander people who smoke: protocol for a hybrid type 1 effectiveness – implementation trial |
| title_full | Mailed smoking cessation support for Aboriginal and Torres Strait Islander people who smoke: protocol for a hybrid type 1 effectiveness – implementation trial |
| title_fullStr | Mailed smoking cessation support for Aboriginal and Torres Strait Islander people who smoke: protocol for a hybrid type 1 effectiveness – implementation trial |
| title_full_unstemmed | Mailed smoking cessation support for Aboriginal and Torres Strait Islander people who smoke: protocol for a hybrid type 1 effectiveness – implementation trial |
| title_short | Mailed smoking cessation support for Aboriginal and Torres Strait Islander people who smoke: protocol for a hybrid type 1 effectiveness – implementation trial |
| title_sort | mailed smoking cessation support for aboriginal and torres strait islander people who smoke protocol for a hybrid type 1 effectiveness implementation trial |
| url | https://bmjopen.bmj.com/content/14/12/e088501.full |
| work_keys_str_mv | AT raglanmaddox mailedsmokingcessationsupportforaboriginalandtorresstraitislanderpeoplewhosmokeprotocolforahybridtype1effectivenessimplementationtrial AT catherinechamberlain mailedsmokingcessationsupportforaboriginalandtorresstraitislanderpeoplewhosmokeprotocolforahybridtype1effectivenessimplementationtrial AT billiebonevski mailedsmokingcessationsupportforaboriginalandtorresstraitislanderpeoplewhosmokeprotocolforahybridtype1effectivenessimplementationtrial AT amanualgetnetmersha mailedsmokingcessationsupportforaboriginalandtorresstraitislanderpeoplewhosmokeprotocolforahybridtype1effectivenessimplementationtrial AT jamiebryant mailedsmokingcessationsupportforaboriginalandtorresstraitislanderpeoplewhosmokeprotocolforahybridtype1effectivenessimplementationtrial AT michellekennedy mailedsmokingcessationsupportforaboriginalandtorresstraitislanderpeoplewhosmokeprotocolforahybridtype1effectivenessimplementationtrial AT nathantaylor mailedsmokingcessationsupportforaboriginalandtorresstraitislanderpeoplewhosmokeprotocolforahybridtype1effectivenessimplementationtrial AT cathysegan mailedsmokingcessationsupportforaboriginalandtorresstraitislanderpeoplewhosmokeprotocolforahybridtype1effectivenessimplementationtrial AT kaydenrobertsbarker mailedsmokingcessationsupportforaboriginalandtorresstraitislanderpeoplewhosmokeprotocolforahybridtype1effectivenessimplementationtrial AT zabowiemills mailedsmokingcessationsupportforaboriginalandtorresstraitislanderpeoplewhosmokeprotocolforahybridtype1effectivenessimplementationtrial AT kadebooth mailedsmokingcessationsupportforaboriginalandtorresstraitislanderpeoplewhosmokeprotocolforahybridtype1effectivenessimplementationtrial AT joleyfoster mailedsmokingcessationsupportforaboriginalandtorresstraitislanderpeoplewhosmokeprotocolforahybridtype1effectivenessimplementationtrial |